


Package Leaflet: Information for the Patient
Dimethyl Fumarate Tevagen 120mg Hard Gastro-Resistant Capsules EFG
Dimethyl Fumarate Tevagen 240mg Hard Gastro-Resistant Capsules EFG
dimethyl fumarate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What is Dimethyl Fumarate Tevagen
Dimethyl Fumarate Tevagen is a medicine that contains dimethyl fumarateas the active substance.
What is Dimethyl Fumarate Tevagen used for
Dimethyl Fumarate Tevagen is used to treat multiple sclerosis (MS) in patients from 13 years of age and older with relapsing-remitting MS.
MS is a long-term disease that affects the central nervous system (CNS), which includes the brain and spinal cord. Relapsing-remitting MS is characterized by repeated attacks (relapses) of neurological symptoms. The symptoms vary from person to person but often include: difficulties with walking, balance problems, and vision problems (e.g., blurred or double vision). These symptoms can disappear completely when the relapse is over, but some problems may remain.
How Dimethyl Fumarate Tevagen works
Dimethyl Fumarate Tevagen seems to work by preventing the body's defense system from damaging the brain and spinal cord. This may also help to delay future disability in MS.
Do not take Dimethyl Fumarate Tevagen
Warnings and precautions
Dimethyl Fumarate can affect your white blood cell count, kidneys, and liver. Before starting Dimethyl Fumarate, your doctor will do a blood test to get a white blood cell count and check that your kidneys and liver are working properly. Your doctor will do regular blood tests during treatment. If you have a low white blood cell count during treatment, your doctor may consider additional tests or stop your treatment.
Tell your doctorbefore starting Dimethyl Fumarate if you have:
Herpes zoster (shingles) may occur during treatment with Dimethyl Fumarate. In some cases, serious complications have occurred. You must tell your doctor immediatelyif you suspect you have any symptoms of shingles.
If you think your MS is getting worse (e.g., weakness or changes in vision) or you notice any new symptoms, talk to your doctor directly, as they could be symptoms of a rare brain infection called PML. PML is a serious disease that can cause death or severe disability.
A rare but serious kidney disorder called Fanconi syndrome has been reported with a medicine containing dimethyl fumarate in combination with other fumaric acid esters, which is used to treat psoriasis (a skin disease). If you notice that you are urinating more, are thirstier and drink more than usual, your muscles seem weaker, you break a bone or simply have aches and pains, tell your doctor as soon as possible so that this can be investigated further.
Children and adolescents
Do not give this medicine to children under 10 years of age because there is no data available for this age group.
Other medicines and Dimethyl Fumarate Tevagen
Tell your doctor or pharmacistif you are taking, have recently taken, or might take any other medicines, in particular:
Taking Dimethyl Fumarate Tevagen with alcohol
After taking Dimethyl Fumarate, you should avoid consuming a small amount (more than 50 ml) of strong alcoholic beverages (with an alcohol content of more than 30%, such as spirits) for the first hour because alcohol may interact with this medicine. This can cause stomach inflammation (gastritis), especially in people who are prone to this condition.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Information on the effects of this medicine when used during pregnancy is limited. Do not use Dimethyl Fumarate during pregnancy unless you have discussed this with your doctor and this medicine is clearly necessary for you.
Breastfeeding
It is not known if the active substance of Dimethyl Fumarate passes into breast milk. Your doctor will inform you whether you should stop breastfeeding, or stop taking Dimethyl Fumarate. This decision will involve weighing the benefits of breastfeeding for your child and the benefits of treatment for you.
Driving and using machines
Dimethyl Fumarate is not expected to affect your ability to drive or use machines.
Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor again.
Starting dose
120mg twice a day.
Take this starting dose for the first 7 days, then take the usual dose.
Usual dose
240mg twice a day.
Dimethyl Fumarate is taken by mouth.
The capsules should be swallowed whole, with some water. Do not break, crush, dissolve, or chew the capsules because this may increase some side effects.
Take Dimethyl Fumarate Tevagen with food– this helps to reduce some of the very common side effects (listed in section 4).
If you take more Dimethyl Fumarate Tevagen than you should
If you take too many capsules, tell your doctor immediately. You may experience side effects similar to those described below in section 4.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Dimethyl Fumarate Tevagen
Do not take a double doseto make up for forgotten doses.
You can take the missed dose if it is at least 4 hours between doses. Otherwise, wait until the next dose.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Dimethyl Fumarate may lower your lymphocyte count (a type of white blood cell). A low white blood cell count can increase the risk of infection, including a rare brain infection called progressive multifocal leukoencephalopathy (PML). PML can cause death or severe disability. PML has occurred after 1 to 5 years of treatment, so your doctor will continue to monitor your white blood cell count during treatment, and you should be aware of any possible symptoms of PML, as described below. The risk of PML may be higher if you have previously taken a medicine that has weakened your immune system.
The symptoms of PML can be similar to those of an MS relapse. The symptoms can include new weakness or worsening weakness on one side of the body; clumsiness; changes in vision, thinking, or memory; or confusion or personality changes, or difficulty speaking and communicating that may persist for more than several days. Therefore, it is very important that you talk to your doctor as soon as possible if you think your MS is getting worse or if you notice any new symptoms while being treated with Dimethyl Fumarate. Also, inform your partner or caregivers about your treatment. It is possible that symptoms may arise that you are not aware of on your own.
Severe allergic reactions
The frequency of severe allergic reactions cannot be estimated from the available data (frequency not known).
Facial or body redness (flushing) is a very common side effect.However, if the redness is accompanied by a skin rash or hivesandyou have any of the following symptoms:
this could be a severe allergic reaction (anaphylaxis).
Other side effects
Very common(may affect more than 1in 10people)
While being treated with Dimethyl Fumarate, it is common for urine tests to show ketones, substances that are naturally produced by the body.
Tell your doctor about these side effects. Your doctor may reduce your dose. Do not reduce the dose unless your doctor tells you to.
Common(may affect up to 1in 10people)
Side effects that may appear in blood or urine tests
Uncommon(may affect up to 1in 100people)
Rare(may affect up to 1in 1000people)
Frequency not known(cannot be estimated from the available data)
Children (13 years of age and older) and adolescents
The side effects described above also apply to children and adolescents.
Some side effects were reported more frequently in children and adolescents than in adults, e.g., headache, stomach pain or cramps, vomiting, sore throat, cough, and painful menstruation.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister, bottle, and carton after EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage temperature.
Keep the medicine in the original packaging to protect it from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Dimethyl Fumarate Tevagen
The active ingredient is dimethyl fumarate.
Dimethyl Fumarate Tevagen 120mg hard gastro-resistant capsules EFG
Each hard gastro-resistantcapsule contains 120 mg of dimethyl fumarate.
Dimethyl Fumarate Tevagen 240mg hard gastro-resistant capsules EFG
Each hard gastro-resistantcapsule contains 240 mg of dimethyl fumarate.
The other ingredients are:
Appearance of the Product and Container Contents
Dimethyl Fumarate Tevagen 120 mg hard gastro-resistant capsules EFG (gastro-resistant capsules): capsules with a white body and a green cap, with a length of 21.4 mm, with printing “DMF 120” in black ink on the body containing white or off-white mini-tablets.
Dimethyl Fumarate Tevagen 240 mg hard gastro-resistant capsules EFG (gastro-resistant capsules): capsules with a green body and cap, with a length of 23.2 mm, with printing “DMF 240” in black ink on the body containing white or off-white mini-tablets.
HDPE bottle with a sealed PP/HDPE cap and silica gel desiccant containing 100 hard gastro-resistant capsules.
Do not swallow the desiccant.
Dimethyl Fumarate Tevagen 120 mg hard gastro-resistant capsules EFG:
Package sizes:
14 capsules (blisters)
14 x 1 capsules (perforated single-dose blisters)
100 capsules (bottle)
Only some package sizes may be marketed.
Dimethyl Fumarate Tevagen 240 mg hard gastro-resistant capsules EFG
Package sizes:
56 capsules (blisters)
56 x 1 capsules (perforated single-dose blisters)
168 capsules (blisters)
168 x 1 capsules (perforated single-dose blisters)
100 capsules (bottle)
196 capsules (blisters)
196 x 1 capsules (perforated single-dose blisters)
Only some package sizes may be marketed.
Marketing Authorization Holder
Teva Pharma, S.L.U.
C/ Anabel Segura, 11, Edificio Albatros B, 1ª planta
Alcobendas (Madrid), 28108, Spain.
Manufacturer
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park,
Paola PLA 3000
Malta
Adalvo Ltd.
Malta Life Sciences Park,
Building 1, Level 4, Sir Temi Zammit Buildings,
San Gwann SGN 3000
Malta
KeVaRo GROUP EOOD
9 Tzaritza Elenora Str. Office 23
Sofia 1618
Bulgaria
Date of the Last Revision of this Leaflet:June 2025
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information on this medicinal product by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/89165/P_89165.html
QR code + URL
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DIMETHYL FUMARATE TEVAGEN 120 mg HARD GASTRO-RESISTANT CAPSULES – subject to medical assessment and local rules.